Prashant Penumadu

17PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersUrban community developmentCancer geneticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Dec 19, 2025
Comparison of Survival Outcomes Among Patients Receiving Chemotherapy with Secondary Cytoreductive Surgery Versus Chemotherapy Alone for Recurrent Epithelial Ovarian, Tubal, or Peritoneal Carcinoma: a Propensity Score-matched Cohort Study.

Anjali Singh, Prasanth Penumadu, Prasanth Ganesan

|Jul 21, 2025
Neoadjuvant Chemotherapy with Low-Dose Nivolumab Leading to Complete Pathological Response in Non-small Cell Lung Carcinoma.

Prasanth Penumadu, Prasanth Ganesan, Dhanapathi Halanaik

|Jun 18, 2025
Perioperative versus adjuvant chemotherapy in carcinoma stomach-A retrospective propensity-matched analysis.

Archana Elangovan, Prasanth Penumadu, Biswajit Dubashi

|May 16, 2024
Clinicopathologic Profile and Treatment Outcomes of Colorectal Cancer in Young Adults: A Multicenter Study From India.

Amit Sehrawat, Mridul Khanna, Smita Kayal

|Dec 22, 2023
Aggressive Histology and Extensive Metastasis Characteristic of Very Young Gastric Cancer (Less Than 30 Years): A Retrospective Clinical Audit.

Narendran Krishnamoorthi, Lourdhusamy Charles, Yadav Nisha

|Feb 06, 2023
'Triton' Tumor of the Lower Alveolus: An Aggressive Variant of Malignant Peripheral Nerve Sheath Tumour.

Karimi Prashob Kumar, Pavneet Kohli, S Dinesh Kumar

Pageof 3

Frequent Collaborators

3 joint publications

Prasanth Ganesan

2 joint publications

Pavneet Kohli

1 joint publications

Debasis Gochhait

1 joint publications

Pooja Sethi